SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
猫好好
Lv4
740 积分
2023-03-30 加入
最近求助
最近应助
互助留言
Identifying effective computerized strategies to prevent drug–drug interactions in hospital: A user-centered approach
25天前
已关闭
The prevalence of drug-drug interactions in cancer therapy and the clinical outcomes
27天前
已完结
The optimization of combinatorial drug therapies: Strategies and laboratorial platforms
1个月前
已完结
Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study
1个月前
已完结
Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America
1个月前
已完结
Burden of gastrointestinal cancers in China from 1990 to 2019 and projection through 2029
1个月前
已完结
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
1个月前
已完结
Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer
1个月前
已完结
Efficacy and Safety of KRASG12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study
1个月前
已完结
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
1个月前
已完结
没有进行任何应助
不需要了【积分已退回】
25天前
感谢,感谢
27天前
感谢,感谢
1个月前
感谢,感谢
1个月前
感谢,感谢
1个月前
感谢,感谢
1个月前
感谢,感谢
1个月前
感谢,感谢
1个月前
感谢,感谢
1个月前
感谢,感谢
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论